UT Wordmark Primary UT Wordmark Formal Shield Texas UT News Camera Chevron Close Search Copy Link Download File Hamburger Menu Time Stamp Open in browser Load More Pull quote Cloudy and windy Cloudy Partly Cloudy Rain and snow Rain Showers Snow Sunny Thunderstorms Wind and Rain Windy Facebook Instagram LinkedIn Twitter email alert map calendar bullhorn

UT News

Teen, Mentor Work Together to Discover a New Treatment for Ovarian Cancer

Event: The Austin Forum on Science, Technology and Society will host “Teen Researcher: Discovering A New Treatment for Ovarian Cancer” presented by Google Global Science Fair gra

Two color orange horizontal divider

Event: The Austin Forum on Science, Technology and Society will host “Teen Researcher: Discovering A New Treatment for Ovarian Cancer” presented by Google Global Science Fair grand prize winner Shree Bose and Dr. Alakananda Basu, professor of molecular biology and immunology and graduate adviser of the cancer biology program at the University of North Texas Health Science Center.

In addition, Verizon will present a $24,750 check to the Texas Advanced Computing Center for education and outreach efforts.

When: 5:45 p.m., Tuesday, March 6. This event is free and open to the public.

Where: ATandT Conference Center Amphitheater, room 204, 1900 University Ave.

Background: Shree Bose of Fort Worth won the grand prize of the first-ever Google Global Science Fair in the 17 to 18-year-old category. Competing against 10,000 students from 91 countries, Bose was selected as the overall winner, earning a $50,000 Google scholarship and a 10-day trip to the Galapagos Islands with a National Geographic expedition, among other prizes.

Under the supervision of Dr. Alakananda Basu, Bose’s award-winning project involved the study of a particular protein, AMP kinase, of interest in cancer cells. Bose investigated a new way to treat patients when they no longer responded to a chemotherapy drug. The research has the potential to affect more than 240,000 patients diagnosed with ovarian cancer who are treated with particular chemotherapy drugs.